Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Nebraska |
---|---|
Information provided by: | University of Nebraska |
ClinicalTrials.gov Identifier: | NCT00756795 |
The general hypothesis of this research is that patients who have undergone treatments for Head Neck Cancer have a decreased quality of life and experience depression and fatigue. Increasing and sustaining physical activity of these patients will improve their emotional well-beings, increase their immunological response, improve wound healing, lessen fatigue and improve their general functionality and quality of life.
The purposes of this study are to: (1) determine the effectiveness of the 12-week exercise intervention program in increasing physical activity in head and neck cancer patients; (2) determine if physically active patients differ in quality of life, depression and fatigue during the course of the study; and (3) determine if the change in physical activity levels is related to changes in the immune responses in human.
Condition | Intervention |
---|---|
Head and Neck Cancer |
Behavioral: Intervention group |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Parallel Assignment, Efficacy Study |
Official Title: | Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study) |
Estimated Enrollment: | 64 |
Study Start Date: | February 2009 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Attention Control: Experimental
5ml of blood will be collected from each blood draw at baseline and post-intervention to assay for Interleukin-6 level. Patient will be taught how to keep the Activity diary to record walking and physical activities. Structured Interview will be conducted at baseline and post-intervention. All patients will receive 3 reminder phone calls during the first week of study and 10 minutes social visits in the following weeks by study coordinator on a weekly basis |
Behavioral: Intervention group
5ml of blood will be collected from each blood draw at baseline and post-intervention to assay for Interleukin-6 level. Structured Interview will be conducted at baseline and post-intervention. Patients assigned to the Intervention group will be given pedometers to obtain distance walked. In addition, patient will be taught how to keep the Exercise diary to record walking and physical activities. All patients will receive 3 reminder phone calls during the first week of study and 10 minutes social visits in the following weeks by study coordinator on a weekly basis. |
Ages Eligible for Study: | 19 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Alvin G Wee, DDS, MS, MPH | 402-559-3910 | awee@unmc.edu |
Contact: Lisa Stamm, BS | 402-559-7992 | lstamm@unmc.edu |
United States, Nebraska | |
University of Nebraska Medical Center | |
Omaha, Nebraska, United States, 68198 |
Principal Investigator: | Alvin G Wee | University of Nebraska |
Responsible Party: | University of Nebraska Medical Center ( Alvin Gerard Wee ) |
Study ID Numbers: | 053-08 |
Study First Received: | September 18, 2008 |
Last Updated: | December 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00756795 History of Changes |
Health Authority: | United States: Institutional Review Board |
Head and Neck Neoplasms |
Neoplasms Neoplasms by Site Head and Neck Neoplasms |